Sunday, 20 July 2014

PHSS Annual Members Conference 2014

Processing challenging Pharmaceutical, Biopharmaceutical and Therapy products to GMP: Managing compliance, control, monitoring and efficiency challenges.

A new conference on interest is taking place  in London on September 12, 2014.

As new Biological products, challenging toxic products and Cellular / Gene therapies (ATMPs) are developed there are increasing challenges in GMP compliance. With more complex products that have increased efficacy and efficiency in targeted delivery systems the challenges in processing and GMP compliance with a focus on patient safety require new strategies, technologies and practice.

The regulatory, product and processing environments are changing and it is important to keep up with these trends.

Today we have to balance the use of Closed and Open system processing technologies, technique and practice to manage risks and interfaces processing large and small batches and for therapies essentially ‘one product, one batch, one patient’.

There is a need to think more strategically on how to approach processing of such products to manage quality, safety, efficacy and patient safety with GMP compliance.

This conference considers the challenges to address, strategies, new technologies and practice developing to meet the new challenges…..not one to miss.
  • Attendance is free to all PHSS Members.
  • Non-members can simply join the PHSS (£90 + vat) so the conference and 12 months membership in one.
The PHSS Bio-contamination monograph will be released at this conference.

For details see: PHSS brochure



Posted by Tim Sandle